VKH
SCLN

Virtu KCG Holdings’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Virtu KCG Holdings’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$832K Buy
+75,610
New +$756K 0.02% 706
2017
Q1 		– Sell
-19,229
Closed -$208K – 4119
2016
Q4 		$208K Buy
+19,229
New +$192K 0.01% 2547
2016
Q2 		– Sell
-25,405
Closed -$279K – 3571
2016
Q1 		$279K Buy
+25,405
New +$226K 0.01% 1774
2014
Q4 		– Sell
-11,595
Closed -$80K – 4466
2014
Q3 		$80K Buy
+11,595
New +$69.5K ﹤0.01% 3239

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's SCLN Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Sciclone Pharmaceuticals Inc (SCLN) in Q2 2017: 75,610 shares worth $832K. The stake represents 0.02% of the portfolio and ranks #706 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in SCLN as recently as Q4 2016.

Virtu KCG Holdings first reported a position in SCLN in Q3 2014 and has held it in 4 quarters since. 142 funds tracked by Wall St. Rank hold SCLN as of Q2 2017.

  • Virtu KCG Holdings held 75,610 shares of Sciclone Pharmaceuticals Inc worth $832K as of Q2 2017.
  • Sciclone Pharmaceuticals Inc was a new Virtu KCG Holdings position in Q2 2017.
  • Sciclone Pharmaceuticals Inc made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #706 holding.
  • Virtu KCG Holdings first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and has held it in 4 quarters since.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.